Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Bayer AG (BAYN.BE)

Compare
20.83
-0.03
(-0.17%)
As of 2:13:02 PM GMT+2. Market Open.
Advanced Chart
Loading Chart for BAYN.BE
  • Previous Close 20.86
  • Open 21.01
  • Bid 20.81 x 27000
  • Ask 20.91 x 627000
  • Day's Range 20.73 - 21.06
  • 52 Week Range 18.65 - 30.99
  • Volume 22
  • Avg. Volume 941
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 13, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: BAYN.BE

View More
View More

Performance Overview: BAYN.BE

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

BAYN.BE
8.16%
DAX P (^GDAXI)
6.59%

1-Year Return

BAYN.BE
20.33%
DAX P (^GDAXI)
19.42%

3-Year Return

BAYN.BE
66.39%
DAX P (^GDAXI)
49.83%

5-Year Return

BAYN.BE
58.46%
DAX P (^GDAXI)
99.71%

Compare To: BAYN.BE

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

BAYN.BE
Bayer AG
20.83
-0.17%
Mkt Cap EUR -
Industry Drug Manufacturers—General
NOVA.SG
Novo Nordisk A/S
53.00
-3.11%
Mkt Cap EUR -
Industry Drug Manufacturers—General
AZN
AstraZeneca PLC
67.05
-1.21%
Mkt Cap 209.921B
Industry Drug Manufacturers—General
BMY
Bristol-Myers Squibb Company
49.36
-1.28%
Mkt Cap 100.436B
Industry Drug Manufacturers—General
LLY
Eli Lilly and Company
734.90
-2.94%
Mkt Cap 659.932B
Industry Drug Manufacturers—General
JNJ
Johnson & Johnson
153.91
+0.19%
Mkt Cap 370.9B
Industry Drug Manufacturers—General
PFE
Pfizer Inc.
22.04
-1.78%
Mkt Cap 124.999B
Industry Drug Manufacturers—General
NVO
Novo Nordisk A/S
62.88
-2.50%
Mkt Cap 282.79B
Industry Drug Manufacturers—General

Statistics: BAYN.BE

View More

Valuation Measures

Annual
As of 4/16/2025

  • Market Cap

    20.59B

  • Enterprise Value

    53.20B

  • Trailing P/E

    --

  • Forward P/E

    8.51

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.44

  • Price/Book (mrq)

    0.64

  • Enterprise Value/Revenue

    1.14

  • Enterprise Value/EBITDA

    6.04

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: BAYN.BE

View More
View More

Company Insights: BAYN.BE

Research Reports: BAYN.BE

View More
View More

People Also Watch

BAYN.F Bayer Aktiengesellschaft
20.80
-0.48%
 
BAYN.SG Bayer AG
20.84
+0.29%
 
0QR3.L PG&E Corporation
17.21
+0.53%
 
0HCB.L Alcoa Corporation
24.45
-0.20%
 
BAS.F BASF SE
41.79
-0.12%
 
BAYN.MU Bayer AG
20.93
+0.70%
 
BAYN.DU Bayer AG
20.89
+0.31%
 
BAYN.DE Bayer Aktiengesellschaft
20.85
-0.50%
 
BAS.DE BASF SE
41.80
-0.48%
 
UNA.AS Unilever PLC
55.48
+0.18%
 
BAYZF Bayer Aktiengesellschaft
23.65
0.00%
 
BN.PA Danone S.A.
73.46
-0.30%
 
1COV.DE Covestro AG
58.70
+0.24%
 
JNJ.DE Johnson & Johnson
136.12
-0.13%
 
WDP.BE The Walt Disney Co
73.51
-0.66%
 
AXPB34.SA American Express Company
148.65
-2.63%